Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals
Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals
Not yet recruiting · NCT07712042 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic disease | Not yet recruiting | Not stated | 2026-07-17 | NCT07712042 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mei Gao | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Qianfoshan Hospital | Ji'nan | China | 1 |